本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bone Biologics Corp

1.26
0.0000
盤後1.260.00000.00%16:04 EDT
成交量:9,908.00
成交額:1.24萬
市值:226.20萬
市盈率:-0.48
高:1.27
開:1.25
低:1.24
收:1.26
52周最高:6.75
52周最低:1.05
股本:179.53萬
流通股本:144.90萬
量比:0.62
換手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):-2.6500
每股收益(LYR):-2.6500
淨資產收益率:-70.17%
總資產收益率:-41.87%
市淨率:0.42
市盈率(LYR):-0.48

資料載入中...

2023/09/30

重要事件披露

Form 8-K - Current report
2023/09/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/13

重要事件披露

Form 8-K - Current report
2023/08/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/06

重要事件披露

Form 8-K - Current report
2023/06/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/17

重要事件披露

Form 8-K - Current report
2023/06/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/06/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/07

重要事件披露

Form 8-K - Current report
2023/06/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/19

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2023/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/21

重要事件披露

8-K - Current report